Germany’s Cannabis Flower Patients Face Years of Litigation After Constitutional Shortcut Blocked
German patients challenging the recent controversial changes to medical cannabis reimbursement via statutory health insurance (GKV) are facing lengthy battles across the country’s courts.
Cannabis Law Report · · 1 min read
It’s all about the GKV-Beitragssatzstabilisierungsgesetz , say that after a few steins!
German patients challenging the recent controversial changes to medical cannabis reimbursement via statutory health insurance (GKV) are facing lengthy battles across the country’s courts.
Business of Cannabis
German patients challenging the recent controversial changes to medical cannabis reimbursement via statutory health insurance (GKV) are facing lengthy battles across the country’s courts.
The GKV-Beitragssatzstabilisierungsgesetz, the cost-saving law that removed dried cannabis flower from statutory reimbursement on July 30, 2026, is thought to have impacted around 65,000 patients across the country.
After the Federal Constitutional Court refused to hear challenges to these changes, the fight has been playing out in Germany’s lower courts.
Patients demanding clarity on whether existing reimbursed prescriptions will continue uninterrupted or whether they must now pay out-of-pocket are now facing a lottery, with different courts issuing different rulings.
Read full article
From Cannabis Law Report, reporting a story first published by businessofcannabis.com.
Information, not legal advice. Check the primary source before relying on it.
